Abstract
A workshop entitled “Regulatory T cells (Treg) and HIV/AIDS” was held in Cincinnati, OH, September 7–8, 2006. This workshop was the first completely dedicated to Treg in HIV infection, and gathered investigators working on different aspects of Treg biology, and on HIV pathogenesis. We report here the major topics of discussion of this workshop, the goal of which was to summarize what is known and not known about the role of Treg in HIV immune responses and pathogenesis; and to foster discussion on the means of manipulating Treg in HIV-infected subjects. Workshop participants also debated the research priorities in the field, which emerged as follows: (1) to arrive at a consensus on Treg definition and to standardize assays aimed at characterizing Treg number and function; (2) to study Treg biology in tissues, notably in mucosal tissues, and at different stages of infection; (3) to examine Treg function in vivo in animal models, as well as to test strategies to target or modulate Treg cell function in these models; (4) to investigate the effect of viral factors on Treg biology, and conversely to study whether Treg activity affects the level of HIV replication; (5) to conduct longitudinal studies of Treg number and function; and (6) to determine the effect of coinfections on Treg biology.
Get full access to this article
View all access options for this article.
